Navigation Links
Drugs Watchdog Faces A Judicial Review

The NHS drugs watchdog will be facing a judicial review in court for the first time. Eisai and Pfizer have been permitted a legal review// over the health watchdog's refusal to approve drugs to treat Alzheimer's disease.

According to the National Institute for Health and Clinical Excellence (Nice), people who are either in the early or in the later stages of Alzheimer's disease cannot be treated with medicines on the NHS. But Eisai and Pfizer mark such assumptions of Nice as ‘irrational’.

Last year Nice declined an appeal over its pronouncement that sufferers with early or late-stage Alzheimer's should not have access to Aricept (donepezil), Reminyl galantamine) or Exelon (rivastigmine). Ebixa (memantine) can be used in clinical studies for sufferers with moderate to severe conditions of Alzheimer's disease.

Judicial review regarding Aricept has been granted to Eisai, the licence holder of Aricept, and Pfizer, its co-promotion partner. This was announced by the companies. Reminyl and Exelon will also be reviewed. As per the activists, patients in the early stages of Alzheimer's also should have access to these drugs which cost around £2.50 a day.

Neil Hunt, chief executive of the Alzheimer's Society which is also involved in this legal battle feels that denying treatment to people who suffer from this devastating disease in the early stages is cruel and unethical. He also added that their legal team will go on to prove that decision of Nice is fundamentally flawed.
JT
'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Emphasis to ban Drugs ads by Doctors
5. Osteoporosis Drugs: right time to take-off
6. Drugs disrupt formation of blood vessels
7. Drugs to stop burgeon of HIV
8. Misleading Advertisements for Prescription Drugs
9. Drugs For Anthrax May Interfere With Oral Contraceptives
10. Over-The-Counter Drugs May Prevent Alzheimers
11. Steps To Improve Quality Of Plant-Based Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: